Clinical Trials Logo

Citation(s)

An Open-Label, Phase 1 Study to Assess the Safety and Tolerability of Bone Marrow Stromal Cell Infusion for the Treatment of Moderate to Severe Inflammatory Bowel Disease

Details for clinical trial NCT01851343